减瘤手术与腹腔内热化疗的麻醉管理：一例报告
Anesthetic management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A case report.
作者信息
Howbora Nilanjana, Sonowal Swaraj J, Borah Tridip J, Kakati Sonai D, Das Anupam, Ninu Marie, Chintey Dokne
机构信息
Department of Anaesthesiology, Critical Care and Pain, Dr. Bhubaneswar Barooah Cancer Institute, Guwahati, Assam, India.
出版信息
Saudi J Anaesth. 2023 Apr-Jun;17(2):272-274. doi: 10.4103/sja.sja_682_22. Epub 2023 Mar 10.
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can significantly influence overall and disease-free survival in selected patients suffering from peritoneal surface malignancies (PSMs). We report here the anaesthetic management of a 52 year old patient of Ca Colon with secondary ovarian and peritoneal deposits. She underwent cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) with curative intent. The advent of CRS/HIPEC gives a promising alternative to conventional treatment modalities but comes with numerous challenges to the anesthesiologist-in view of the metabolic and hemodynamic adjustments-and demands training.
细胞减灭术（CRS）和腹腔内热灌注化疗（HIPEC）可显著影响部分腹膜表面恶性肿瘤（PSM）患者的总生存期和无病生存期。我们在此报告一名52岁患有结肠癌并伴有继发性卵巢和腹膜转移的患者的麻醉管理情况。她接受了旨在治愈的细胞减灭术（CRS）和腹腔内热灌注化疗（HIPEC）。CRS/HIPEC的出现为传统治疗方式提供了一种有前景的替代方案，但鉴于代谢和血流动力学调整，给麻醉医生带来了诸多挑战，并且需要培训。
Zotero 插件